Arca Biopharma | ABIO - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Alterity Therapeutics Limited AUD 1.73M 2.77M 2025-12
Amgen USD 25.5B 547M 2026-06
Arca Biopharma USD 22.97M 6.34M 2026-06
Biogen USD 3.92B 918.2M 2026-06
Brainstorm Cell Therapeutics USD 12.38M 621K 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Capricor Therapeutics USD 32.96M 676K 2026-06
Cipla INR 70.14B 7.16B 2026-03
Clal Biotechnology ILS 6.66M 3.75M 2023-12
Compugen USD 22.04M 533K 2026-03
CSL USD 4.61B 207M 2025-12
Cytokinetics USD 181.43M 17.76M 2026-06
Daiichi Sankyo JPY 765.7B 119.32B 2026-06
Gilead Sciences USD 11.02B 1.54B 2026-06
GlaxoSmithKline GBP 21.53B 895M 2026-06
Grifols EUR 2.37B 156.97M 2025-12
Laboratory Of America USD 2.12B 516.4M 2026-06
Myriad Genetics USD 130.7M 500K 2026-06
Otsuka Holdings JPY 738.96B 52.85B 2026-06
Pfizer USD 32.65B 1.7B 2026-06
United Therapeutics USD 607.8M 8.7M 2026-06